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Introduction
EPAC (Exchange Proteins Activated by cAMP) belongs to a novel class of cAMP receptors (de Rooij et al., 1998; Bos, 2006) . There are two isoforms of EPAC proteins and each has multiple domains, consisting of one (EPAC1) or two (EPAC2) cAMP regulatory binding motifs (Kawasaki et al., 1998; Rehmann et al., 2003) . Both EPAC1 and EPAC2 proteins are expressed throughout the brain, including in the hippocampus, striatum, and prefrontal cortex (Zhang et al., 2009; Yang et al., 2012) . To determine their neurological functions, we developed mutant strains of mice with deficiency in expression of either EPAC1 (EPAC1 Ϫ/Ϫ ) or EPAC2 (EPAC2 Ϫ/Ϫ ) or both (EPAC Ϫ/Ϫ ) genes (Yang et al., 2012) . We showed previously that combined deletion of both the EPAC1 and EPAC2 genes (EPAC Ϫ/Ϫ ) reduces glutamate release from the presynaptic terminals (Yang et al., 2012) .
Transmitter release involves several steps of interactions between synaptic and vesicle fusion proteins (Südhof, 1995; Schneggenburger and Neher, 2005; Haucke et al., 2011) and requires Ca 2ϩ influx into the terminals (Stanley, 1997; Jackson and Chapman, 2008 ). Previously, we described ATP-sensitive potassium (K ATP ) channels consisting of Kir6.1 subunit and type-1 sulfonylurea receptor (SUR1) at the presynaptic terminals in the hippocampus (Soundarapandian et al., 2007) . K ATP channels are gated by metabolic factors such as ATP/ADP ratios (Ashcroft and Gribble, 1998; Schwappach et al., 2000) . In pancreatic ␤-cells, K ATP channels are associated directly with EPAC2 protein and thus control Ca 2ϩ -dependent secretion of insulin (Zhang et al., 2009 ). However, whether EPAC interacts with K ATP channels in the central neurons is not known.
In the present study, we used a gene-targeting approach combined with electrophysiological recordings to show that EPAC physically and functionally interacts with K ATP channels via direct inhibition of the SUR1 receptor in the dentate granule cells. We found that this inhibition controls glutamate release and seizure vulnerability in adult mice.
Materials and Methods
Development of EPAC mutant mice. The conditional mutant strain of mice with a selective deletion of EPAC1 gene in the hippocampus (EPAC1 Ϫ/Ϫ mice) was generated by gene targeting in 129Sv embryonic stem cells, as described previously (Yang et al., 2012) . EPAC2-null mutant (EPAC2 Ϫ/Ϫ ) mice were generated using a gene-trapping approach in 129Sv mouse embryonic stem cells (Yang et al., 2012) . A double mutant strain of mice (EPAC Ϫ/Ϫ mice) was developed by crossing EPAC1 Ϫ/Ϫ mice with EPAC2 Ϫ/Ϫ mice. SUR1 Ϫ/Ϫ mice were purchased from The Jackson Laboratory and bred with EPAC Ϫ/Ϫ mice, resulting in the EPAC Ϫ/Ϫ /SUR1 Ϫ/Ϫ mice. Care and experiments with animals were in accordance with institutional guidelines and those of the animal care and use committees of Huazhong University of Science and Technology (Wuhan, China) and the Louisiana State University Health Sciences Center (New Orleans).
Co-IP experiments. Synaptosomes were prepared as described previously (Peng et al., 2006; Soundarapandian et al., 2007) . Briefly, the hippocampal homogenate in 0.32 M sucrose was centrifuged for 10 min at 1400 ϫ g to yield a pellet (P1) and a supernatant (S1). S1 was centrifuged for another 10 min at 13,800 ϫ g, yielding a crude synaptosomal pellet (P2) and a supernatant (S2). P2 was resuspended in 0.32 M sucrose con-taining 1 mM NaHCO 3 and layered on top of a discontinuous sucrose gradient (0.8, 1.0, and 1.2 M). After centrifugation for 2 h at 82,500 ϫ g, the synaptosomes were recovered as a band, resuspended in 0.32 M sucrose and 1 mM NaHCO 3 plus protease inhibitors, pelleted, and resuspended in HEPES buffer containing protease inhibitors.
Synaptosomes were incubated with 1% Triton X-100 for 20 min on ice and centrifuged at 14,000 g for 15 min to obtain the supernatant. Protein concentration in the extracts was determined by Lowry assay (Bio-Rad). The extracts (ϳ500 g of protein) were incubated with polyclonal rabbit anti-EPAC1 (2 g) or anti-EPAC2 (2 g) overnight at 4°C, followed by the addition of 40 l of Protein G-Sepharose (Sigma) for 3 h at 4°C. Immunoprecipitates were washed four times with PBS, denatured with SDS sample buffer, separated by SDS-PAGE, and blotted with anti-Kir6.1 (1:100; Santa Cruz Biotechnology), anti-SUR1, or antisyntaxin-1A (1:400; Santa Cruz Biotechnology) antibodies.
Electrophysiology. The slices (350 m) of the hippocampus were cut from male mice at 90 Ϯ 5 d of age and placed in a holding chamber for at least 1 h. A single slice was then transferred to the recording chamber and submerged and perfused with artificial CSF (2 ml/min) that had been saturated with 95% O 2 /5% CO 2 . The composition of the artificial CSF was as follows (in mM): 124 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 2 MgCl 2 , 2 CaCl 2 , 26 NaHCO 3 , and 10 dextrose. Whole-cell patch-clamp recordings (5 M⍀) at voltage-clamp mode were visualized with infrared differential interference contrast using an Axioskop 2FS equipped with Hamamatsu C2400 -07E optics, as described previously (Peng et al., 2006; Tu et al., 2010; Yang et al., 2012) .
The internal pipette solution for whole-cell patch-clamp recordings contained the following (in mM): 132.5 cesium gluconate, 17.5 CsCl, 0.05 EGTA, 10 HEPES, 2 Mg-ATP, and 0.5 GTP, pH 7.4 (290 mOsm). NMDA receptor-mediated EPSCs were evoked by paired-pulse stimulation of the mossy fiber tracks in the hilus of the dentate gyrus using bipolar tungsten electrodes and recorded with Axopatch 200 B amplifiers and monitored by computer using pClamp11 at 35°C in the presence of 10 M bicuculline and 20 M NBQX at a holding potential of ϩ60 mV. The spontaneous EPSCs were recorded in the presence of 100 M AP5 and 10 M bicuculline at a holding potential of Ϫ70 mV. The threshold (ϳ6 pA) for detection was set at 3ϫ the baseline SD from a template of 0.5 ms rise time and 10 ms decay. Cells with a noisy or unstable baseline (5 min after break-in) were discarded.
For single-channel recordings from the dentate granule cell in the hippocampus, the pipette solution contained the following (in mM): 140 potassium methanesulfonate (KMeS), 10 HEPES, 2 CaCl 2 , 10 TEA-Cl, 2 CsCl, 1 4-aminopyridine (4-AP), 100 nM charybdotoxin, and 100 nM aparmin, pH 7.4 (290 mOsm).
Generation of rAAV1/2 virus particles. SUR1 859 -881 (dhlmqagilellrddkrtvvlvt) and its scrambled control (lmqdhllrdagilellvlvtkrt) were cloned into the rAVE construct containing eGFP through ApaI/KpnI (GenDetect), creating rAVE-CAP/ SUR1
859 -881 -IRES-eGFP vectors. The rAVE plasmids were cotransfected with the AAV helper1 and helper 2 into HEK293 cells to generate the rAAV1/2 virus particles. Generation of the infectious virus particles (Ͼ5 ϫ 10 12 genomic particle/ml) were described previously (Peng et al., 2006; Tu et al., 2010) . Activated virus particles were coded by experimenters. Other experimenters, who were unaware of the coded particles, injected the particles (2 l at 0.2 l/min) into each side of the dorsal hippocampus (3.1 mm posterior to bregma; 2.3 mm lateral to the midline; 2.9 mm below dura). ϩ/ϩ mice (A,B) and SUR1 Ϫ/Ϫ mice (C) and precipitated using antibodies against EPAC1 and EPAC2 or Kir6.1 and SUR1, as indicated. The precipitates were blotted with antibodies against EPAC1, EPAC2, SUR1, Kir6.1, and syntaxin-1A. Input: 20 g of proteins without precipitation were loaded. Similar results were seen in each of the four experiments. D, Synaptosomes were precipitated using GST-EPAC2 1-158 , GST-EPAC2 206 -334 , or GST-EPAC2 351-458 and blotted with anti-SUR1. Input: 20 g of protein without precipitation was blotted with antibodies against GST and SUR1, as indicated. Similar results were seen in each of the four experiments. E, GST-EPAC2 351-458 or GST alone was coexpressed with Flag-tagged SUR1 859 -881 in HEK293 cells. Then, 72 h after expression, cell lysates were precipitated using anti-GST and blotted with anti-Flag antibody. Input: 10 g of proteins without precipitation were loaded. Similar results were seen in each of the four experiments. F, was coexpressed with Flag-tagged SUR1 859 -881 in HEK293 cells. Then, 72 h after expression, cell lysates were precipitated using anti-GST in the presence of 5 g/ml SUR1 859 -881 peptide or its scrambled control (S-SUR1 859 -881 ) and blotted with anti-Flag antibody. Similar results were seen in each of the five experiments. G, H, The rAAV1/2 vector (G) for expression of SUR1
859 -881 and a representative image (H ) of the dentate gyrus area taken 15 d after injection of the rAAV1/2-CAP/SUR1
859 -881 -IRES-eGFP virus particles. Synaptosomes were prepared from the dentate gyrus 15 d after expression of SUR1 859 -881 (lane 1) or its scrambled control (lane 0) and precipitated with anti-EPAC1 and anti-EPAC2, respectively. The precipitates were blotted with antibodies against EPAC1, EPAC2, or SUR1, as indicated. Similar results were seen in each of the five experiments.
Kainic acid treatment and behaviors. Adult male mice (age 90 Ϯ 5 d, 28 Ϯ 2 g of body weight) were injected intraperitoneally with a single dose of kainic acid (KA; 25-40 mg/kg in PBS, A.G. Scientific). Mice were monitored continuously for 3 h. The severity of seizures was rated by the arbitrary scale, with 1 ϭ staring and immobility/wet dog shake, 2 ϭ hyperactivity, repetitive movements, rearing, and falling, 3 ϭ low seizures (intense shivering), 4 ϭ severe tonic/clonic convulsion, and 5 ϭ death. The averaged points for seizure severity in a given group were expressed as the seizure index, as described previously (Soundarapandian et al., 2007) .
Statistical analysis. Data were analyzed using SPSS 11.0 statistical software. All data are expressed as mean Ϯ SEM. Statistical significance was determined by one-way ANOVA followed by a Student-Newman-Keuls post hoc test with 95% confidence and Student's two-tailed t test.
Results
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To search for an interaction between EPAC and K ATP channels, we precipitated the EPAC protein complex in the hippocampus of adult mice. Blots of the precipitates revealed that EPAC proteins were physically associated with the K ATP channel components, including the Kir6.1 subunit and the SUR1 receptor ( Fig.  1 A, B) . This association was eliminated in SUR1 Ϫ/Ϫ mice (Fig.  1C) , revealing that the SUR1 receptor acts as an intermediary between EPAC and Kir6.1 channels. As a positive control, we blotted the precipitates with anti-syntaxin-1A, a functional component of synaptic vesicle proteins that is known to interact with SUR1 receptor in the central neurons (Chang et al., 2011; Zhou et al., 2012) . To validate this association, we generated a series of truncation mutants of SUR1 and EPAC proteins (Fig. 1 D, E) and found that a GST-EPAC2 protein consisting of amino acids 351-458 (GST-EPAC2 351-458 ) was able to pull down endogenous SUR1 receptor in synaptosomes from the hippocampus of adult mice (Fig. 1D) . Coexpression of GST-EPAC2
351-458 with Flag-SUR1 859 -881 in HEK293 cells revealed that the EPAC2 protein bound directly to the SUR1 receptor (Fig. 1E) . Direct binding between GST-EPAC2 351-458 and Flag-SUR1 859 -881 was verified by a peptide-blocking experiment (Fig. 1F ) in which a synthesized SUR1 859 -881 peptide at a concentration of 5 g/ml sufficiently inhibited an association of GST-EPAC2 351-458 with Flag-SUR1 859 -881 . To examine whether SUR1 859 -881 intercepts EPAC association with SUR1 in brain cells in vivo, we expressed SUR1 859 -881 in the hippocampus of adult mice using the rAAV1/2 virus vector (Fig. 1G) . Fifteen days after expression, we precipitated endogenous EPAC proteins. Western blots of the precipitates revealed that SUR1 859 -881 uncoupled EPAC proteins from SUR1 receptor in the hippocampus (Fig. 1H ) , demonstrating that EPAC is physically associated with K ATP channels via direct binding between EPAC2
351-458 and SUR1 859 -881 .
Increased open probability of K ATP channels in EPAC ؊/؊ mice K ATP channels consist of inwardly rectifying K ϩ channels (Kir6.1, Kir6.2) and regulatory sulfonylurea receptors (SUR1, SUR2A, and SUR2B), which are members of the ATP-binding cassette proteins (Ashcroft and Gribble, 1998; Schwappach et al., 2000) . A combination of the different subunits forms different types of K ATP channels in different cell types. We showed previously that the presynaptic K ATP channel consists of the Kir6.1 subunit and the SUR1 receptor in the hippocampus (Soundarapandian et al., 2007) . Therefore, we investigated here whether EPAC regulates the Kir6.1/SUR1 type of K ATP channels functionally. We performed single-channel recordings in the dentate granule cells of EPAC Ϫ/Ϫ mice and compared them with EPAC ϩ/ϩ mice ( Fig.   2A ). Open-and closed-channel distributions are shown in Figure  2B , C. We found that genetic deletion of EPAC genes increased open probability (P open ) of K ATP channels. This increase was absent in both SUR1 Ϫ/Ϫ and Kir6.1 Ϫ/Ϫ mice (Fig. 2D ). An increase of P open was also seen in the wild-type mice expressing SUR1 859 -881 (Fig. 2E ), indicating that EPAC proteins regulate K ATP channel open probability via a direct inhibition of the SUR1 receptor.
Reduced glutamate release probability in EPAC
؊/؊ mice Our prior studies showed that SUR1 receptor is associated with synaptic vesicle proteins at the presynaptic terminals (Soundarapandian et al., 2007) . We thus investigated here whether an increase of K ATP channel open probability in EPAC Ϫ/Ϫ mice alters glutamate transmitter release. We first analyzed the spontaneous EPSCs and found that their frequency was reduced in EPAC Ϫ/Ϫ mice compared with wild-type controls, whereas the mean amplitude did not differ between genotypes (Fig. 3A-D) . We next recorded the paired-pulse facilitation of the evoked EPSCs at mossy fiber-CA3 synapses. To measure glutamate release from the mossy-fiber terminal accurately and to avoid the polysynaptic responses within CA3-CA3 synaptic inputs, we recorded NMDA-receptor-mediated EPSCs in the presence of 20 M NBQX. We found that EPAC Ϫ/Ϫ mice displayed greater paired-pulse facilitation than wild-type controls, with the greatest effects at the shortest interstimulus interval (Fig.  3E,F) . This facilitation increased with an elevation of Ca 2ϩ (Fig. 3G) . Therefore, EPAC Ϫ/Ϫ mice have a reduction of Ca 2ϩ -dependent glutamate release probability at the mossy-fiber terminals. The similar reduction of glutamate release was achieved by interception of EPAC-SUR1 association via expressing SUR1 859 -881 peptide. Therefore, an interaction between EPAC and the SUR1 receptor regulates Ca 2ϩ -dependent glutamate release.
Reduced seizure vulnerability in EPAC
؊/؊ mice Our earlier study revealed that, compared with the wild-type controls, mutant mice lacking the SUR1 gene (SUR1 Ϫ/Ϫ ) or the Kir6.1 gene (Kir6.1 Ϫ/Ϫ ) are vulnerable to epileptic seizures (Soundarapandian et al., 2007) , a severe neurological disorder that is known to be associated with an increased glutamate release (Ben-Ari and Cossart, 2000). We thus hypothesized that an increase of K ATP channel open probability in EPAC Ϫ/Ϫ mice reduces seizure sensitivity. To test this hypothesis, we examined adult mice for seizure activity after KA administration. The latency and severity of seizures were diagnosed and expressed as a seizure index with increased KA doses (Fig. 4A) . We found that the majority of EPAC ϩ/ϩ mice (96%, n ϭ 15 mice) underwent status epileptic seizures such as hyperactivity, constant rearing, and falling. Eleven of 15 mice exhibited tonic convulsion and died within 3 h when a single dose of 40 mg/kg was administered (Fig. 4A) . When a single dose of 30 mg/kg was administered, the seizure index of EPAC ϩ/ϩ mice was of 3.62 Ϯ 0.51 (mean Ϯ SEM, n ϭ 15, Fig. 4B ). In striking contrast, few EPAC Ϫ/Ϫ mice progressed in severity to the extent of EPAC ϩ/ϩ mice; 10 of 11 EPAC Ϫ/Ϫ mice had no convulsive responses and remained alive throughout the course of observations with a seizure index of 1.38 Ϯ 0.16 (mean Ϯ SEM, n ϭ 11). The similar reduction of epileptic seizures was observed in wild-type mice expressing SUR1 859 -881 (Fig. 4B) . Therefore, EPAC protein confers seizure vulnerability through direct inhibition of the SUR1 receptor.
Discussion
In our previous studies (Soundarapandian et al., 2007) , we reported that a combination of the Kir6.1 subunit with the SUR1 receptor form neuronal-type K ATP channels that are located predominantly at the presynaptic terminals. Genetic inhibition of either the Kir6.1 subunit or the SUR1 receptor enhances glutamate transmitter release, leading to the induction of epileptic seizures in adult mice (Soundarapandian et al., 2007) . In the present study, we identified EPAC proteins as the functional interactive components of the Kir6.1/SUR1 type of K ATP channels in the dentate granule cells. Genetic deletion of EPAC genes or disruption of EPAC-SUR1 interaction increased the open probability of K ATP channels substantially, thus counteracting epileptic seizures occurring in the SUR1 Ϫ/Ϫ mice. This finding indicates that EPAC controls K ATP channel activity via tonic inhibition of the SUR1 receptor at the presynaptic terminals, as illustrated in Figure 4C , D.
Previous studies using pharmacological reagents showed that the EPAC protein regulates vesicular release probability in the central neurons (Sakaba and Neher, 2003; Zhong and Zucker, 2005) , but the mechanism underlying this regulation remained unknown. In the present study, we have shown that EPAC proteins are associated with K ATP channels via a direct binding between EPAC2 and the SUR1 receptor. K ATP channels are gated by intracellular metabolic factors and opening of the channels hyperpolarizes cells, leading to a reduction of Ca 2ϩ -dependent transmitter release (Fig. 4C ). An increase of intracellular Ca 2ϩ could be caused by either Ca 2ϩ influx from voltage-dependent Ca 2ϩ channels or Ca 2ϩ release from the intracellular stores (Collin et al., 2005; Sharma et al., 2008) . Deletion of EPAC genes or the interception of EPAC-SUR1 binding increases the open probability of K ATP channels in the dentate granule neurons (Fig.  4D) . Therefore, it is plausible that EPAC proteins control transmitter release at the granule cell terminals via a direct inhibition of the SUR1 receptor.
Several rare, nonsynonymous variants of EPAC genes have been reported in patients with autism spectrum disorders (Bacchelli et al., 2003) , but whether these mutations cause autistic behaviors remains unknown (Woolfrey et al., 2009) . Autism patients are diagnosed with abnormalities of social interactions and mental retardation (Geschwind and Levitt, 2007) . Some patients also exhibit spontaneous epileptic seizures (Walsh et al., 2008) . Recently, we demonstrated that the EPAC mutation causes defects in spatial learning and social interactions (Yang et al., 2012) .
In the present study, we have also shown that the EPAC mutation elevates seizure vulnerability. We conclude that disruption of EPAC signaling may represent a molecular mechanism underlying the expression of autistic phenotypes. 
